EA202190930A1 - LOW MOLECULAR MENIN INHIBITORS - Google Patents

LOW MOLECULAR MENIN INHIBITORS

Info

Publication number
EA202190930A1
EA202190930A1 EA202190930A EA202190930A EA202190930A1 EA 202190930 A1 EA202190930 A1 EA 202190930A1 EA 202190930 A EA202190930 A EA 202190930A EA 202190930 A EA202190930 A EA 202190930A EA 202190930 A1 EA202190930 A1 EA 202190930A1
Authority
EA
Eurasian Patent Office
Prior art keywords
low molecular
menin
menin inhibitors
inhibitors
formula
Prior art date
Application number
EA202190930A
Other languages
Russian (ru)
Inventor
Шаомэн Ван
Шилинь Сюй
Анхело Агилар
Лиюэ Хуан
Тяньфэн Сюй
Мэн Чжан
Жэньци Сюй
Фумин СЮЙ
Хайбинь Чжоу
Тао Лю
Original Assignee
Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган
Аджиос Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган, Аджиос Фармасьютикалз, Инк. filed Critical Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган
Priority claimed from PCT/US2019/053904 external-priority patent/WO2020072391A1/en
Publication of EA202190930A1 publication Critical patent/EA202190930A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В изобретении представлены соединения формулы Iи их фармацевтически приемлемые соли и сольваты, где R1a, R1b, R1c, E, G и Q такие, как определены в описании изобретения. Настоящее изобретение также обеспечивает соединения формулы I для применения для лечения рака или любого другого заболевания, состояния или расстройства, которое реагирует на ингибирование менина.The invention provides compounds of formula I, and their pharmaceutically acceptable salts and solvates, wherein R1a, R1b, R1c, E, G and Q are as defined herein. The present invention also provides compounds of Formula I for use in the treatment of cancer or any other disease, condition or disorder that responds to inhibition of menin.

EA202190930A 2018-10-03 2019-09-30 LOW MOLECULAR MENIN INHIBITORS EA202190930A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862740567P 2018-10-03 2018-10-03
PCT/US2019/053904 WO2020072391A1 (en) 2018-10-03 2019-09-30 Small molecule menin inhibitors

Publications (1)

Publication Number Publication Date
EA202190930A1 true EA202190930A1 (en) 2021-07-06

Family

ID=77443285

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190930A EA202190930A1 (en) 2018-10-03 2019-09-30 LOW MOLECULAR MENIN INHIBITORS

Country Status (1)

Country Link
EA (1) EA202190930A1 (en)

Similar Documents

Publication Publication Date Title
PH12019500231A1 (en) N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors
EA202092590A1 (en) PYRIDAZINONES AS PARP7 INHIBITORS
CY1125214T1 (en) N-((ET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDE COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS
PH12020551464A1 (en) Cd73 inhibitors
CY1123810T1 (en) TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS KALLIKREIN INHIBITORS IN HUMAN PLASMA
EA201891203A1 (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
EA201990187A1 (en) PYRIMIDINE ANTIPROLIFERATION AGENTS
GEP20237506B (en) Pcsk9 antagonist compounds
MX2020012165A (en) Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer.
EA201890308A1 (en) SUBSTITUTED ASO COMPOUNDS AS IRAK-4 INHIBITORS
EA201390609A1 (en) HIDANTOIN DERIVATIVES USEFUL AS KV3-CHANNEL INHIBITORS
EA201790078A1 (en) MNK INHIBITORS AND RELATED METHODS
EA201992320A1 (en) PIPERIDINES AS COVALENT MENIN INHIBITORS
BR112016015236A2 (en) serine / threonine kinase inhibitors
EA201692470A1 (en) PHARMACEUTICAL COMBINATIONS
PH12021550374A1 (en) Small molecule menin inhibitors
CY1121554T1 (en) PRODUCER OF PYRANOCHROMENYL-PHENOLIS, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF METABOLIC SYNDROME OR INFLAMMATORY DISEASE
MX2018004664A (en) Ep4 antagonists.
CY1121334T1 (en) MOVEMENT INHIBITOR AURORA A
TW201613577A (en) Pharmaceutical combinations
MX2018013164A (en) Novel substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase.
CY1124907T1 (en) KALLIKREIN INHIBITORS IN HUMAN PLASMA
EA201992721A1 (en) METHODS FOR OBTAINING AND APPLICATION OF PDE9 INHIBITORS
EA202191358A1 (en) NEW COMPOUNDS AND THEIR APPLICATION IN TREATMENT
EA202090424A1 (en) BICYCLIC HISTONDEACETYLASE INHIBITORS